Group One Trading’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-28,300
| Closed | -$5.2M | – | 9147 |
|
|
2021
Q2 | $5.2M | Sell |
28,300
-11,700
| -29% | -$2.01M | 0.01% | 1655 |
|
|
2021
Q1 | $6.12M | Sell |
40,000
-356,000
| -90% | -$55.1M | 0.01% | 1339 |
|
|
2020
Q4 | $61.9M | Buy |
396,000
+85,300
| +27% | +$11M | 0.11% | 142 |
|
|
2020
Q3 | $35.6M | Buy |
310,700
+78,100
| +34% | +$8.43M | 0.11% | 142 |
|
|
2020
Q2 | $26.1M | Buy |
232,600
+22,100
| +10% | +$2.35M | 0.12% | 152 |
|
|
2020
Q1 | $18.9M | Buy |
210,500
+145,800
| +225% | +$14.3M | 0.15% | 108 |
|
|
2019
Q4 | $7M | Sell |
64,700
-47,200
| -42% | -$5.05M | 0.05% | 504 |
|
|
2019
Q3 | $11M | Buy |
111,900
+66,800
| +148% | +$7.53M | 0.09% | 247 |
|
|
2019
Q2 | $5.91M | Buy |
45,100
+38,000
| +535% | +$4.9M | 0.05% | 429 |
|
|
2019
Q1 | $960K | Sell |
7,100
-14,000
| -66% | -$1.74M | 0.01% | 1439 |
|
|
2018
Q4 | $2.05M | Buy |
21,100
+8,800
| +72% | +$1.04M | 0.02% | 1022 |
|
|
2018
Q3 | $1.71M | Sell |
12,300
-16,400
| -57% | -$2.06M | 0.01% | 1278 |
|
|
2018
Q2 | $3.56M | Sell |
28,700
-177,700
| -86% | -$20.8M | 0.03% | 730 |
|
|
2018
Q1 | $23M | Buy |
206,400
+176,500
| +590% | +$21.1M | 0.23% | 71 |
|
|
2017
Q4 | $3.58M | Sell |
29,900
-82,600
| -73% | -$10.1M | 0.03% | 827 |
|
|
2017
Q3 | $15.8M | Sell |
112,500
-2,800
| -2% | -$380K | 0.14% | 140 |
|
|
2017
Q2 | $14M | Buy |
115,300
+109,600
| +1,923% | +$12.8M | 0.15% | 143 |
|
|
2017
Q1 | $691K | Sell |
5,700
-12,700
| -69% | -$1.64M | 0.01% | 1617 |
|
|
2016
Q4 | $2.25M | Buy |
+18,400
| New | +$2.25M | 0.02% | 853 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM